title: The in vitro and in vivo anti-metastatic efficacy of oxythiamine and the possible mechanisms of action.
abstract: This study examined the anti-metastatic effects of oxythiamine (OT) both in cell culture and in vivo. Cell culture results revealed that OT (0-20 microM) significantly inhibited the invasion and migration (IC(50) = 8.75 microM) of Lewis lung carcinoma (LLC) cells. These effects of OT were accompanied by the inhibition of metalloproteinases-2 and -9 (MMP-2, MMP-9), urokinase-type plasminogen activator (uPA) activities and by the increases in protein expression of tissue inhibitors of metalloproteinases-1 and -2 (TIMP-1, TIMP-2). We then implanted (s.c.) C57BL/6 mice with LLC cells and supplemented the mice with a low- or a high-dose of OT (250 or 500 mg/kg BW) daily for 5 wk. During the 5-wk period, OT supplementation decreased plasma MMP-2 activity in a dose-dependent manner, and this effect was significant after 4 wk of tumor cell implantation. Tumor metastasis was found to confine to the lungs of mice injected with the tumor cells. High-OT supplementation strongly lowered the number and area of tumors and inhibited protein expression of MMP-2 and MMP-9 in the lungs. In addition, high-OT supplementation markedly decreased the extent of proliferating cell nuclear antigen (PCNA) staining in the lungs. By contrast, OT supplementation increased TIMP-1 and -2 protein expression in the lungs. These results demonstrate that OT supplementation attenuates tumor cell metastasis, possibly via inhibition of protein expression of MMPs, extent of PCNA staining and via increase of proteins expression of TIMPs.
authors.affiliation: Department of Food Science and Biotechnology, National Chung Hsing University, 250 Kuo Kuang Road, Taichung, 402, Taiwan, ROC.
authors.forename: Chih-Min
authors.initials: CM
authors.lastname: Yang
authors.forename: Yi-Zih
authors.initials: YZ
authors.lastname: Liu
authors.forename: Jiunn-Wang
authors.initials: JW
authors.lastname: Liao
authors.forename: Miao-Lin
authors.initials: ML
authors.lastname: Hu
mesh_terms: D000818:Animals; D015153:Blotting, Western; D018827:Carcinoma, Lewis Lung / Q000188:drug therapy* / Q000473:pathology; D002448:Cell Adhesion; D045744:Cell Line, Tumor; D004305:Dose-Response Relationship, Drug; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D009368:Neoplasm Transplantation; D010119:Oxythiamine / Q000627:therapeutic use*
chemical_list: D010119:Oxythiamine
references.citation: Ann Surg Oncol. 2002 Aug;9(7):668-74
references.pmid: 12167581
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: Cancer Res. 1997 Oct 1;57(19):4242-8
references.pmid: 9331084
references.citation: Biol Chem. 1997 Mar-Apr;378(3-4):151-60
references.pmid: 9165065
references.citation: Nihon Rinsho. 1995 Jul;53(7):1805-10
references.pmid: 7630023
references.citation: Cancer Res. 1996 Jan 1;56(1):190-6
references.pmid: 8548762
references.citation: Vet Pathol. 2005 Jul;42(4):405-26
references.pmid: 16006601
references.citation: Oncology. 1976;33(5-6):250-2
references.pmid: 1026857
references.citation: Acta Biochim Pol. 2007;54(2):315-22
references.pmid: 17502925
references.citation: Anticancer Res. 1998 Jan-Feb;18(1B):595-602
references.pmid: 9568183
references.citation: FEBS Lett. 1999 Jul 30;456(1):113-8
references.pmid: 10452541
references.citation: Nature. 1987 Apr 2-8;326(6112):515-7
references.pmid: 2882423
references.citation: Cancer Res. 2003 Jun 1;63(11):2940-7
references.pmid: 12782601
references.citation: Int J Cancer. 2006 Dec 15;119(12):2733-41
references.pmid: 17019714
references.citation: Invasion Metastasis. 1989;9(3):192-208
references.pmid: 2722434
references.citation: Cancer Res. 1998 Mar 1;58(5):1048-51
references.pmid: 9500469
references.citation: Int J Cancer. 1995 Nov 27;63(5):680-7
references.pmid: 7591285
references.citation: FASEB J. 1994 Apr 1;8(6):401-7
references.pmid: 7513289
references.citation: Cancer. 1996 Apr 15;77(8 Suppl):1676-80
references.pmid: 8608561
references.citation: Int J Oncol. 1998 Jun;12(6):1343-8
references.pmid: 9592197
references.citation: Anal Biochem. 1994 May 1;218(2):325-9
references.pmid: 8074288
references.citation: Cancer Res. 2007 Apr 1;67(7):3310-9
references.pmid: 17409440
references.citation: Med Hypotheses. 1998 Jun;50(6):501-6
references.pmid: 9710324
references.citation: FASEB J. 1999 May;13(8):781-92
references.pmid: 10224222
references.citation: Arch Pathol Lab Med. 1987 Sep;111(9):841-5
references.pmid: 2888448
references.citation: Biochim Biophys Acta. 2005 May 25;1755(1):37-69
references.pmid: 15907591